Olema Pharmaceuticals (OLMA) Cash & Equivalents (2020 - 2026)
Olema Pharmaceuticals (OLMA) reported Cash & Equivalents of $48.6 million for Q2 2026, down 7.4% from $52.47 million a year earlier and down 7.5% from the prior quarter.
Olema Pharmaceuticals (OLMA) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Olema Pharmaceuticals posted Cash & Equivalents of $48.3 million, down 65.4% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $139.48 million in FY2024 (+103.5%), $68.54 million in FY2023 (+189.2%), $23.7 million in FY2022 (+71.6%) and $13.81 million in FY2021 (-95.9%).
- Five-year quarterly Cash & Equivalents spans a low of $13.81 million in Q4 2021 and a high of $139.48 million in Q4 2024.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 28.0%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2023 (growth of 338.0%); the low point was Q4 2021 (a decline of 95.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $52.55 million (Q1 2026), $48.3 million (Q4 2025) and $35.26 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Olema Pharmaceuticals | 719.73 Mn | 719.73 Mn | - | 48.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.60 Mn |
| Mar 31, 2026 | 52.55 Mn |
| Dec 31, 2025 | 48.30 Mn |
| Sep 30, 2025 | 35.26 Mn |
| Jun 30, 2025 | 52.47 Mn |
| Mar 31, 2025 | 50.64 Mn |
| Dec 31, 2024 | 139.48 Mn |
| Sep 30, 2024 | 35.89 Mn |
| Jun 30, 2024 | 16.89 Mn |
| Mar 31, 2024 | 33.72 Mn |
| Dec 31, 2023 | 68.54 Mn |
| Sep 30, 2023 | 117.41 Mn |
| Jun 30, 2023 | 34.96 Mn |
| Mar 31, 2023 | 40.92 Mn |
| Dec 31, 2022 | 23.70 Mn |
| Sep 30, 2022 | 26.80 Mn |
| Jun 30, 2022 | 24.53 Mn |
| Mar 31, 2022 | 21.51 Mn |
| Dec 31, 2021 | 13.81 Mn |
| Sep 30, 2021 | 25.60 Mn |
Olema Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OLMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OLMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OLMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();